SHSCX Holdings Information

SHSCX is a mutual fund with a total of 162 individual holdings. The top holdings are Johnson & Johnson stock at 10.93%, Eli Lilly and Company at 10.32%, Merck & Co. at 5.32%, AbbVie at 4.19%, and Gilead Sciences at 4.02%.

Total Holdings

162

Top 10 Percentage

49.16%

Asset Class

Equity

Fund Category

Health

Assets

5.85B

Forward PE Ratio

19.00

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	10.93%	2,688,331
2	LLY	Eli Lilly and Company	10.32%	674,971
3	MRK	Merck & Co., Inc.	5.32%	2,661,458
4	ABBV	AbbVie Inc.	4.19%	1,157,700
5	GILD	Gilead Sciences, Inc.	4.02%	1,736,422
6	AMGN	Amgen Inc.	3.44%	588,158
7	UNH	UnitedHealth Group Incorporated	3.05%	677,911
8	PFE	Pfizer Inc.	2.75%	5,899,018
9	VRTX	Vertex Pharmaceuticals Incorporated	2.69%	361,907
10	ISRG	Intuitive Surgical, Inc.	2.45%	319,051
11	ABT	Abbott Laboratories	2.33%	1,361,894
12	EW	Edwards Lifesciences Corporation	2.28%	1,710,975
13	TMO	Thermo Fisher Scientific Inc.	2.15%	263,085
14	DHR	Danaher Corporation	1.94%	615,018
15	TSTXX	BlackRock Liquidity Funds - T-Fund	1.87%	112,293,243
16	TEVA	Teva Pharmaceutical Industries Limited	1.74%	3,475,093
17	BSX	Boston Scientific Corporation	1.55%	1,484,205
18	ARGX	argenx SE	1.47%	121,340
19	SYK	Stryker Corporation	1.46%	267,707
20	MDT	Medtronic plc	1.26%	876,373
21	LON: AZN	AstraZeneca PLC	1.24%	384,355
22	REGN	Regeneron Pharmaceuticals, Inc.	1.13%	87,659
23	BIIB	Biogen Inc.	1.11%	364,188
24	BMY	Bristol-Myers Squibb Company	1.11%	1,097,084
25	INSM	Insmed Incorporated	1.07%	392,149

Showing 25 of 162 holdings

Subscribe to see the full list

Activate Now

As of Mar 31, 2026